This event is dedicated to fostering partnerships and collaboration amongst industry, governments, payers, investors and patients. It is about expediting orphan drug development and articulating its value, from discovery to patient access, so that manufacturers are guaranteed full and speedy reimbursement.
Because your customers are here continuously looking for new strategies and technologies to expedite orphan drugs to patients.
• Understand how to access various markets
• Know how to price orphan drugs
• Ascertain reimbursement
• Identify, access and better relate to rare disease patients
• Evaluate new technologies and drug development strategies
• Learn how to manage risk and costs
• Improve ROI
• Form new strategic partnerships